Showing results (141-150 of 23,016) with videos related to
Sort By:
Pageof 2,302
British Journal of Pharmacology|July 2, 2010
AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladderS Sinha, S Gupta, S Malhotra, et al.British Journal of Pharmacology|July 2, 2010
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavirR A B van Waterschoot, R ter Heine, E Wagenaar, et al.British Journal of Pharmacology|July 2, 2010
Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytesH Joos, W Albrecht, S Laufer, et al.British Journal of Pharmacology|July 2, 2010
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusTerry K W Ma, Kevin K H Kam, Bryan P Yan, et al.British Journal of Pharmacology|July 2, 2010
A series of structurally novel heterotricyclic alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor-selective antagonistsM B Gill, S Frausto, M Ikoma, et al.British Journal of Pharmacology|July 2, 2010
The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channelsA Singh, M E Hildebrand, E Garcia, et al.British Journal of Pharmacology|July 2, 2010
Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cellsAda Ledonne, Mauro Federici, Michela Giustizieri, et al.British Journal of Pharmacology|July 2, 2010
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humansClara Sciorati, Roberta Buono, Emanuele Azzoni, et al.British Journal of Pharmacology|July 29, 2010
Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injuryJulio Gómez-Soriano, Eider Goiriena, Julian TaylorBritish Journal of Pharmacology|August 20, 2010
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletionX Wu, T Kihara, H Hongo, et al.Pageof 2,302